HAL (France)open access
Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas
0, Mesothelioma, Personalized medicine, Molecular alteration, 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 250295
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.